Poolbeg Pharma PLC (AIM:POLB) has announced that chief executive Jeremy Skillington upped his stake in the firm on Wednesday.
Skillington bought 154,764 ordinary shares at 10.8p each, the company said on Thursday, taking his stake in Poolbeg to 873,497 shares, or 0.17%.